Log In
Print
BCIQ
Print
Print this Print this
 

recAP (recombinant Alkaline Phosphatase)

  Manage Alerts
Collapse Summary General Information
Company AM-Pharma B.V.
DescriptionIV recombinant human alkaline phosphatase
Molecular Target Lipopolysaccharide (LPS)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I
Standard IndicationRenal damage
Indication DetailsTreat acute kidney injury (AKI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today